Antigenics Oncophage Well Ahead of Dendreon (NASDAQ:AGEN) - TapeBeat PDF Print
TapeBeatIn 2006, Antigenics announced top-line results from the first part of the phase III study of Oncophage in renal cell carcinoma. The trial did not meet its

... read more

 
Share |
Copyright © 2026 Global Dialysis. All Rights Reserved.